United Kingdom · Question · Written question
UIN 96896
Prostate Cancer: Olaparib
Original
Introduced
29 September 2020
Last action
22 October 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
22 October 2020
Summary
To ask the Secretary of State for Health and Social Care, when Olaparib will be made available for the treatment of prostate cancer on the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 September 2020
Written question
To ask the Secretary of State for Health and Social Care, when Olaparib will be made available for the treatment of prostate cancer on the NHS.
Source: Commons
22 October 2020
Answer
The National Institute for Health and Care Excellence is currently developing technology appraisal guidance on olaparib for previously treated, hormone-relapsed metastatic prostate cancer with homologous recombination repair gene mutations. The first comm...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-09-29/96896
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1238883
- uk · wq-1238883 · source updated 22 October 2020